CRANNMED LTD
Desconocido
EmboSure: Disruptive, drug free treatment of knee osteoarthritis using novel materials and minimally invasive...
CRANNMED LTD
tramitó un
HORIZON EUROPE:
HORIZON-EIC-2021-ACCELERATOROPEN-01
EmboSure is a breakthrough treatment for Knee Osteoarthritis. It acts directly on the mechanism of Osteoarthritis, delivers long term pain r...
2022-04-04 - 2024-07-31 | Financiado
2022-04-04 - 2024-07-31 | Financiado
ADDEGE: Dramatically improving chronic knee pain from osteoarthritis using an active steering telescopic mic...
CRANNMED LTD
tramitó un
H2020:
H2020-EIC-SMEInst-2018-2020
Chronic knee pain from osteoarthritis (OA) is prevalent in 12% of the global population over the age of 60 (Yuji Okuno,
Amine Korchi, Takuma...
2019-07-18 - 2019-12-31 | Financiado
2019-07-18 - 2019-12-31 | Financiado
* No se disponen de datos de la empresa actual.